ArticleFrontiers in medicine2026
Evaluating dopamine D2 receptor gene polymorphisms and peripheral inflammatory cytokines in ICU delirium: a two-stage exploratory observational study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Delirium is a prevalent form of acute brain dysfunction in the Intensive Care Unit (ICU). Its pathogenesis is multifactorial, involving neurotransmitter imbalance and neuroinflammation. While Dopamine D2 receptor (DRD2) signaling is central to delirium pathophysiology, the association between specific DRD2 single nucleotide polymorphisms (SNPs) and ICU delirium remains understudied in Chinese populations. This study aimed to investigate the association of DRD2 polymorphisms (rs6275, rs6277) and inflammatory cytokines with the development of delirium in critically ill patients. Methods: This prospective observational study enrolled 200 adult patients admitted to the ICU of Lanzhou University Second Hospital between January 2021 and May 2022. Patients were screened for delirium twice daily using the Confusion Assessment Method for the ICU (CAM-ICU). Genomic DNA was extracted to genotype DRD2 SNPs (rs6275 and rs6277). In a subset of 100 patients, serum inflammatory markers (IL-6, IL-8, and TNF-ɑ) were quantified by ELISA. Multivariate logistic regression was performed to identify independent risk factors, and a nomogram was constructed to visualize risk prediction. Results: Of the 200 patients, 28 (14.0%) developed delirium. Genotyping revealed no significant difference in rs6275 distribution between groups. However, the rs6277 genotype distribution differed significantly ( Conclusion: The DRD2 rs6277 CC genotype is associated with ICU delirium risk in our primary cohort, while elevated serum TNF-ɑ represents a correlated inflammatory marker in a separate validation subgroup. These parallel findings independently support the genetic and neuroinflammatory hypotheses of delirium. However, larger integrated cohorts are required to confirm their potential intersecting mechanistic pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.